Dow Up2.00% Nasdaq Up1.66%

More On TEVA


Teva Pharmaceutical Industries Limited (TEVA)

-NYSE
55.75 Up 1.67(3.09%) Feb 12, 4:00PM EST
|After Hours : 54.94 Down 0.81 (1.46%) Feb 12, 4:10PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 20,272,000   20,314,000   20,317,000  
Cost of Revenue9,216,000  9,607,000  9,665,000  
Gross Profit 11,056,000   10,707,000   10,652,000  
Operating Expenses
Research Development1,488,000  1,427,000  1,356,000  
Selling General and Administrative5,078,000  5,319,000  5,117,000  
Non Recurring539,000  2,312,000  1,974,000  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 3,951,000   1,649,000   2,205,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes3,951,000  1,649,000  2,205,000  
Interest Expense313,000  399,000  386,000  
Income Before Tax3,638,000  1,250,000  1,819,000  
Income Tax Expense591,000  (43,000)(137,000)
Minority Interest13,000  16,000  53,000  
Net Income From Continuing Ops3,055,000  1,269,000  1,963,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 3,055,000   1,269,000   1,963,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 3,055,000   1,269,000   1,963,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.